Haritha Samaranayake

654 total citations
20 papers, 513 citations indexed

About

Haritha Samaranayake is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Haritha Samaranayake has authored 20 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Genetics and 6 papers in Oncology. Recurrent topics in Haritha Samaranayake's work include Virus-based gene therapy research (9 papers), Glioma Diagnosis and Treatment (4 papers) and Herpesvirus Infections and Treatments (4 papers). Haritha Samaranayake is often cited by papers focused on Virus-based gene therapy research (9 papers), Glioma Diagnosis and Treatment (4 papers) and Herpesvirus Infections and Treatments (4 papers). Haritha Samaranayake collaborates with scholars based in Finland, United States and Sweden. Haritha Samaranayake's co-authors include Seppo Ylä‐Herttuala, Thomas Wirth, Jere T. Pikkarainen, J K Räty, Ann‐Marie Määttä, Thomas Wirth, Taina Vuorio, Hanna P. Lesch, Karen S. Moulton and Suvi E. Heinonen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Haritha Samaranayake

20 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haritha Samaranayake Finland 12 297 154 150 73 69 20 513
Marcio C. Bajgelman Brazil 18 407 1.4× 125 0.8× 123 0.8× 23 0.3× 121 1.8× 45 735
Stephen J. Zoog United States 15 439 1.5× 234 1.5× 253 1.7× 55 0.8× 136 2.0× 31 725
Sandrine Vessillier United Kingdom 12 198 0.7× 175 1.1× 76 0.5× 74 1.0× 120 1.7× 29 475
Kamel Chettab France 14 180 0.6× 142 0.9× 58 0.4× 58 0.8× 81 1.2× 31 479
Mikael Varga Sweden 15 314 1.1× 120 0.8× 161 1.1× 43 0.6× 217 3.1× 19 736
Douglas G. Osborne United States 15 332 1.1× 113 0.7× 66 0.4× 32 0.4× 182 2.6× 20 643
Cohava Gelber United States 9 236 0.8× 104 0.7× 83 0.6× 23 0.3× 142 2.1× 18 530
Tom C. Tsang United States 15 287 1.0× 131 0.9× 96 0.6× 21 0.3× 95 1.4× 32 578
Katie Binley United Kingdom 13 559 1.9× 72 0.5× 147 1.0× 74 1.0× 76 1.1× 22 784
Tatiana Flisikowska Germany 16 536 1.8× 144 0.9× 381 2.5× 24 0.3× 50 0.7× 40 808

Countries citing papers authored by Haritha Samaranayake

Since Specialization
Citations

This map shows the geographic impact of Haritha Samaranayake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haritha Samaranayake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haritha Samaranayake more than expected).

Fields of papers citing papers by Haritha Samaranayake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haritha Samaranayake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haritha Samaranayake. The network helps show where Haritha Samaranayake may publish in the future.

Co-authorship network of co-authors of Haritha Samaranayake

This figure shows the co-authorship network connecting the top 25 collaborators of Haritha Samaranayake. A scholar is included among the top collaborators of Haritha Samaranayake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haritha Samaranayake. Haritha Samaranayake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schindler, Christoph, Jacek Mikosiński, Igor Mierau, et al.. (2024). Multi-target gene therapy AUP1602-C to improve healing and quality of life for diabetic foot ulcer patients: a phase I, open-label, dose-finding study. Therapeutic Advances in Endocrinology and Metabolism. 15. 2455663414–2455663414. 5 indexed citations
2.
3.
Aaltonen, Niina, Prosanta Singha, Hermina Jakupović, et al.. (2020). High-Resolution Confocal Fluorescence Imaging of Serine Hydrolase Activity in Cryosections – Application to Glioma Brain Unveils Activity Hotspots Originating from Tumor-Associated Neutrophils. Biological Procedures Online. 22(1). 6–6. 8 indexed citations
4.
Leinonen, Hanna, Igor Oruetxebarria, Haritha Samaranayake, et al.. (2019). Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells. Molecular Therapy — Methods & Clinical Development. 15. 63–71. 19 indexed citations
5.
Ylä‐Herttuala, Seppo, et al.. (2018). Up-regulation of Mismatch Repair Pathway by Suicide Gene Therapy: Implications on the use of Temozolomide Treatment in Malignant Glioma. Journal of Cancer Science & Therapy. 10(8). 1 indexed citations
6.
Samaranayake, Haritha, et al.. (2015). Tomato thymidine kinase-based suicide gene therapy for malignant glioma—an alternative for Herpes Simplex virus-1 thymidine kinase. Cancer Gene Therapy. 22(3). 130–137. 8 indexed citations
7.
Gynther, Mikko, Tiina M. Kääriäinen, Jenni J. Hakkarainen, et al.. (2014). Brain Pharmacokinetics of Ganciclovir in Rats with Orthotopic BT4C Glioma. Drug Metabolism and Disposition. 43(1). 140–146. 15 indexed citations
8.
Vuorio, Taina, Harri Nurmi, Karen S. Moulton, et al.. (2014). Lymphatic Vessel Insufficiency in Hypercholesterolemic Mice Alters Lipoprotein Levels and Promotes Atherogenesis. Arteriosclerosis Thrombosis and Vascular Biology. 34(6). 1162–1170. 92 indexed citations
9.
Samaranayake, Haritha, et al.. (2013). Improved therapeutic effect on malignant glioma with adenoviral suicide gene therapy combined with temozolomide. Gene Therapy. 20(12). 1165–1171. 14 indexed citations
10.
Leinonen, Hanna, Anna‐Kaisa Ruotsalainen, Ann‐Marie Määttä, et al.. (2012). Oxidative Stress-Regulated Lentiviral TK/GCV Gene Therapy for Lung Cancer Treatment. Cancer Research. 72(23). 6227–6235. 37 indexed citations
11.
Wirth, Thomas, et al.. (2012). Increased invasion of malignant gliomas after 15-LO-1 and HSV-tk/ganciclovir combination gene therapy. Cancer Gene Therapy. 19(12). 870–874. 7 indexed citations
12.
Samaranayake, Haritha, et al.. (2012). Specific Inhibition of SRC Kinase Impairs Malignant Glioma Growth In Vitro and In Vivo. Molecular Therapy — Nucleic Acids. 1. e19–e19. 6 indexed citations
13.
Wirth, Thomas, et al.. (2012). The Syngeneic BT4C Rat Malignant Glioma is a Valuable Model to study Myelomonocytic cells in Tumors. SHILAP Revista de lepidopterología. 5. CGM.S9314–CGM.S9314. 3 indexed citations
14.
Wirth, Thomas, Jere T. Pikkarainen, Haritha Samaranayake, et al.. (2012). Efficient gene therapy based targeting system for the treatment of inoperable tumors. The Journal of Gene Medicine. 14(4). 221–230. 4 indexed citations
15.
Lesch, Hanna P., Cristina Peixoto, Tiago Vicente, et al.. (2011). Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors. Gene Therapy. 18(6). 531–538. 48 indexed citations
16.
Samaranayake, Haritha, Ann‐Marie Määttä, Jere T. Pikkarainen, & Seppo Ylä‐Herttuala. (2010). Future Prospects and Challenges of Antiangiogenic Cancer Gene Therapy. Human Gene Therapy. 21(4). 381–396. 19 indexed citations
17.
Samaranayake, Haritha, et al.. (2009). Challenges in monoclonal antibody-based therapies. Annals of Medicine. 41(5). 322–331. 137 indexed citations
18.
Lesch, Hanna P., Jere T. Pikkarainen, Minna U. Kaikkonen, et al.. (2009). Avidin Fusion Protein-Expressing Lentiviral Vector for Targeted Drug Delivery. Human Gene Therapy. 20(8). 871–882. 12 indexed citations
19.
Wirth, Thomas, Haritha Samaranayake, Jere T. Pikkarainen, Ann‐Marie Määttä, & Seppo Ylä‐Herttuala. (2009). Clinical trials for glioblastoma multiforme using adenoviral vectors.. PubMed. 11(5). 485–92. 19 indexed citations
20.
Määttä, Ann‐Marie, Haritha Samaranayake, Jere T. Pikkarainen, Thomas Wirth, & Seppo Ylä‐Herttuala. (2009). Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma. Current Gene Therapy. 9(5). 356–367. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcio C. Bajgelman Breakdown of academic impact, for papers by Stephen J. Zoog Breakdown of academic impact, for papers by Sandrine Vessillier Breakdown of academic impact, for papers by Kamel Chettab Breakdown of academic impact, for papers by Mikael Varga Breakdown of academic impact, for papers by Douglas G. Osborne Breakdown of academic impact, for papers by Cohava Gelber Breakdown of academic impact, for papers by Tom C. Tsang Breakdown of academic impact, for papers by Katie Binley Breakdown of academic impact, for papers by Tatiana Flisikowska
Rankless by CCL
2026